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The guest editors of this special issue are pleased to pres-
ent a compendium of original research and review articles
focusing on molecular mechanisms underlying age-related
ocular diseases.
According to the World Health Organization (WHO),
the 65-and-over global population is predicted to almost
double over the next three decades. By 2050, less than
one-ﬁfth of the world’s old population will reside in more
developed countries; the functional visual decline associated
with the elderly thus creates a challenge to be met by the
national healthcare systems of industrialized countries. The
WHO has identiﬁed some irreversible diseases, such as age-
related macular degeneration (AMD), diabetic retinopathy,
and glaucoma, as priority eye diseases in terms of prevention
of visual impairment and blindness.
The lack of eﬀective therapies for prevention or cure of
such widespread sight-threatening diseases is mainly due to
the insuﬃcient understanding of the molecular and cellular
events underlying the disease onset or progression. For this
reason, basic scientiﬁc studies shedding light on the molecu-
lar and cellular responses to physiological/pathological stim-
uli (such as oxidative stress) are of great relevance and may
help to translate pioneering “bench to bedside” research into
eﬀective clinical strategies.
After the awarding of 1974 Nobel Prize to Christian De
Duve, who discovered the lysosomes and coined the term
autophagy, and the awarding of 2016 Nobel Prize to Yoshi-
nori Ohsumi for his discoveries of the mechanisms of
autophagy, the importance of autophagy in physiological
and pathological contexts has come to the forefront. The
number of peer-reviewed publications with autophagy as a
keyword has doubled in the last 5 years, at the present pass-
ing 32,500 papers. Accordingly, autophagy has been object
of several contributions of this special issue.
Recent observations reveal that autophagy is declined
in advanced AMD. J. Blasiak et al. wrote a review article
for cellular senescence in AMD, the most common cause
of irreversible blindness in the elderly of industrialized coun-
tries. Increased oxidative stress, protein aggregation, and
inﬂammation are likely contributors to AMD pathology.
Authors discussed cross talk of oxidative stress, DNA dam-
age response, autophagy, and senescence in the retinal
pigment epithelium (RPE) cell. Likewise, the article by
L. F. Hernandez-Zimbron et al. provided a review of some
AMD-related factors and mainly focused on feasible treat-
ments targeting autophagy, oxidative stress, VEGF, and glial
cell dysfunction, emphasizing the increasing relevance of
stem cell-based research as a promising area in biology.
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Despite signiﬁcant breakthrough in the understanding
of how autophagy modulates cellular processes, the entire
puzzle of autophagy-related pathways is not yet completely
elucidated. In particular, the role of posttranscriptional
control of gene expression in autophagy is poorly character-
ized. Findings of the research article entitled “Autophagy
stimulus promotes early HuR protein activation and p62/
SQSTM1 protein synthesis in ARPE-19 cells by triggering
Erk1/2, p38MAPK, and JNK kinase pathways” by N. Marchesi
et al. focused on the early events occurring in response to
a proautophagy stimulus and supported modulation of the
autophagy-regulating kinases as a potential therapeutic tar-
get for AMD.
One of the factors promoting inﬂammation in AMD is
lipid oxidation. Mao et al. provided in vitro and in vivo
evidence that oxidized low-density lipoprotein (ox-LDL)
promoted laser-induced choroidal neovascularization by
increasing VEGF/PDGF and CYLD (tumor suppressor
cylindromatosis) levels. The authors also proposed salvia-
nolic acid A as a novel potential therapeutic reagent for
exudative AMD in virtue of its beneﬁcial antagonism on
the ox-LDL-induced eﬀects.
Many age-related ocular pathologies are multifactorial
and are triggered by consecutive or overlapping insults that
are hard to eliminate. The recovery of retinal health in spite
of injury and the preservation (or reinforce) of its physiolog-
ical defense thus represent a valuable strategy to ﬁght factors
that harm vision.
Several publications provide evidence that indicate a
protective association between dietary antioxidant intake
and the incidence of oxidative stress-related ocular dis-
eases. D. Rajapakse et al. underlined the importance of
physiological concentration of zinc for retina’s homeosta-
sis. In their in vitro study, the authors showed that zinc
supplementation protects RPE cells from oxidative stress-
induced death by improving mitochondrial function and
preventing lysosome rupture.
The context of cytoprotection, of interest, is also the
original in vitro study by S. Davinelli et al., showing that
citicoline and homotaurine cotreatment protects primary
cultured retinal cells from glutamate and high-glucose-
induced neurotoxicity. Another contribution in the identiﬁ-
cation of molecules endowed with neuroprotective eﬀects
came from the in vitro study by Pittalà et al., who suggested
the new nature-inspired NO-releasing compound VP10/39
as a promising candidate to protect RPE cells against oxida-
tive stress, via induction of the Nrf2/Keap1/HO-1 pathway.
To this regard, one of the most comprehensive tran-
scription systems to neutralize oxidative stress and main-
tain cellular homeostasis in the retina is the Keap1-Nrf2-
ARE pathway, whose impairment has been associated with
ageing. The review on the “Involvement of Nrf2 in Ocular
Diseases” by S. Batliwala et al. provided thorough informa-
tion regarding the relationship of Nrf2 and various age-
related ocular pathologies, giving a perspective on possible
therapeutic or preventive approaches targeting the Keap1-
Nrf2-ARE pathway.
Novel cellular and animal models are needed to better
understand the pathogenesis of age-related ocular diseases
and to screen potential drugs. In this context, the origi-
nal basic scientiﬁc study by A. Smedowski et al., on the
FluoroGold-labeled organotypic retinal explant culture
(FLOREC), proposed a new interesting and versatile ex vivo
method to detect neurotoxicity/neurodegeneration in the
retina and to test potential neuroprotective agents.
Among age-related conditions is the dry eye syndrome,
which aﬀects also young population and counts more than
300 million people worldwide suﬀering from this disease.
The in vivo study by E. Y. Zernii et al. showed that the
mitochondrial-targeted antioxidant SkQ1 is able to suppress
oxidative stress and stimulate intrinsic antioxidant activity in
the cornea and also improve the stability of the tear ﬁlm.
Likewise, a contribution in the context of ocular surface
inﬂammation came from the study entitled “Cyclodextrin
enhances corneal tolerability and reduces ocular toxicity
caused by diclofenac” by H. Abdelkader et al., investigating
the use of cyclodextrins (CDs) to reduce ocular toxicity of
NSAIDs, speciﬁcally diclofenac (Diclo). The authors pro-
vided in vitro and in vivo evidence that Diclo-γ-CD and
Diclo-HP-β-CD inclusion complexes are able to reduce
diclofenac-induced ocular toxicity and show fast healing
rates without scar formation.
We hope the papers are informative for basic researchers,
clinician scientists, and patients who are aﬀected by age-
related ocular conditions.
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